A good update to “How I treat ATLL” is out in . Remember ✔️ CNS ppx (we use triple IT, can do IT or HD MTX) ✔️ Shimoyma criteria are imperfect, treat aggressive chronic and cutaneous as acute ✔️ Refer to trials (like IL-15/mogamulizumab)